Literature DB >> 23361996

Twin anemia-polycythemia sequence in a case of monoamniotic twins.

W Diehl1, P Glosemeyer, M Tavares De Sousa, B Hollwitz, G Ortmeyer, K Hecher.   

Abstract

Twin anemia-polycythemia sequence (TAPS) complicates up to 6% of monochorionic diamniotic twin pregnancies, typically in the late second or third trimester. The presence of only a few and very small arteriovenous vascular anastomoses characterizes the underlying angioarchitecture at the chorionic plate in cases of TAPS. In monoamniotic twins, large vascular anastomoses can usually be seen at the placental vascular equator, and therefore one would not expect the development of TAPS in monoamniotic twins. We report a case of TAPS in a monoamniotic pregnancy at 26 + 5 weeks' gestation which responded favorably to fetoscopic laser coagulation of the small placental anastomoses, resolving severe anemia in one twin and polycythemia in the other. The pregnancy continued until 32 + 5 weeks, when worsening cord entanglement with increased resistance and the development of postsystolic notches in the umbilical artery of one twin prompted delivery by Cesarean section. There was only a moderate difference in neonatal hemoglobin concentrations, with the former polycythemic twin needing a single partial volume exchange transfusion. The postnatal course of the neonates was uneventful, according to their gestational age at birth. To our knowledge this is the first case report describing successful laser therapy for TAPS in monoamniotic twins.
Copyright © 2013 ISUOG. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2013        PMID: 23361996     DOI: 10.1002/uog.12418

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  1 in total

1.  Prediction of Amnionicity Using the Number of Yolk Sacs in Monochorionic Multifetal Pregnancy.

Authors:  Sue Yeon Park; Jin Hoon Chung; You Jung Han; Si Won Lee; Moon Young Kim
Journal:  J Korean Med Sci       Date:  2017-12       Impact factor: 2.153

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.